Online presentations and Skype conversations replaced handshakes and face-to-face comparisons, while still managing to attract the interest of over 200 international investors who assessed the projects and business plans of five new companies operating in the circular bioeconomy and four active in life sciences.
The finalists were selected thanks to a path that began in January with a national roadshow between Naples, Catania, Bari, Rome, Padua and Trento, which collected hundreds of candidates. The experience then continued for 20 realities through a training course curated by Bill Barber, coach and Head of Evaluation and Startup Acceleration of Intesa Sanpaolo Innovation Center. At the end of the process, the protagonists presented their project to an audience of selectors chosen from financial investors, sector experts and business managers. The nine finalist startups finally had access to the Investment Forum streamed.
“Today more than ever, biotechnology is proving its extraordinary value: they are the essential key to offering a concrete response to the Coronavirus emergency, but also an important resource for a sustainable restart”, says Riccardo Palmisano, president of Assobiotec-Federchimica. “We are proud of the results achieved thanks to BioInItaly, which since 2008 has allowed us to raise over 60 million euros of investments in 25 national innovative startups. The project has selected and trained more than 150 startups, bringing them to the meeting with more ‘of 1,900 companies, investors and ecosystem players laying the foundations for their growth. “
RESERVED REPRODUCTION © Copyright ANSA